Share on StockTwits

Cardiovascular Systems (NASDAQ:CSII) CEO David Martin unloaded 13,957 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $29.03, for a total transaction of $405,171.71. Following the sale, the chief executive officer now directly owns 394,937 shares of the company’s stock, valued at approximately $11,465,021. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Cardiovascular Systems (NASDAQ:CSII) traded up 1.84% on Monday, hitting $29.87. The stock had a trading volume of 166,076 shares. Cardiovascular Systems has a 52 week low of $18.83 and a 52 week high of $37.73. The stock has a 50-day moving average of $28.88 and a 200-day moving average of $30.32. The company’s market cap is $924.7 million.

Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.31) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.28) by $0.03. The company had revenue of $39.56 million for the quarter, compared to the consensus estimate of $37.21 million. The company’s quarterly revenue was up 37.3% on a year-over-year basis. On average, analysts predict that Cardiovascular Systems will post $-1.11 earnings per share for the current fiscal year.

A number of research firms have recently commented on CSII. Analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems from $38.00 to $42.00 in a research note on Thursday, August 7th. They now have a “buy” rating on the stock. Analysts at Needham & Company LLC raised their price target on shares of Cardiovascular Systems from $37.00 to $38.00 in a research note on Thursday, August 7th. They now have a “strong-buy” rating on the stock. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $40.67.

Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.

Receive News & Ratings for Cardiovascular Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.